SFMBT2 and Familial prostate cancer: Immunohistochemical analysis indicated increased numbers of Pref-1 and CD29 positive cells in prostate cancer induced by intraprostatic injection of LNCaP cells stably transfected with SFMBT2 shRNA (Figure 2A).